The prescribing of psychotropic medications for people with an intellectual disability has changed. In many locations across England, antidepressants have become the most widely prescribed psychotropic. In the context of the current NHS England STOMP programme to reduce inappropriate psychotropic prescribing for people with intellectual disability, there is an urgent need to understand whether this change reflects evidence-based use of the medications involved. There has been little analysis into the benefits or problems associated with the change and whether it is of concern. This paper offers a variety of possible explanations and opportunities to improve clinical practice and policy.

为智障人士开具精神药物的处方发生了变化。在英格兰的许多地方，抗抑郁药已成为最广泛使用的精神药物。在当前 NHS England STOMP 计划的背景下，该计划旨在减少对智障人士的不当精神药物处方，迫切需要了解这种变化是否反映了所涉及药物的循证使用。几乎没有分析与变化相关的好处或问题，以及它是否值得关注。本文为改进临床实践和政策提供了多种可能的解释和机会。